| Financial Year |
March 31 2023 |
| Monetary Funds |
57,356,270.40 |
| Held-for-trading Financial Assets |
121,909,514.78 |
| Notes Receivable |
2,500,000.00 |
| Accounts Receivable |
95,540,557.47 |
| Advances to Suppliers |
55,428,379.87 |
| Other Receivables |
10,399,923.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
124,192,839.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,220,048.61 |
| Other Current Assets |
3,542,536.32 |
| Total Current Assets |
488,826,070.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
96,155,436.46 |
| Investment Properties |
-- |
| Fixed Assetes |
314,875,338.36 |
| Under-construction Projects |
410.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,905,688.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,773,932.11 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
2,486,436.93 |
| Sub-Total of Non-Current Assets |
498,197,241.91 |
| Total Assets |
987,023,312.42 |
| Short-Term Loans |
23,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
31,251,113.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,003,263.14 |
| Taxes Payable |
2,915,005.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,638,213.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,000,000.00 |
| Other Current Liabilities |
3,525,314.38 |
| Sub-Total of Current Liabilities |
194,450,455.63 |
| Long-term Loans |
13,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,347,452.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,629,156.80 |
| Total Liabilities |
221,079,612.43 |
| Paid-In Capital(Or Share Stock) |
538,395,000.00 |
| Capital Surplus |
489,991,037.59 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-342,918,071.52 |
| Minority Stockholder's Interest |
80,475,733.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
685,467,966.07 |
| Owner's Equity（Stockholder's Equity） |
765,943,699.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
987,023,312.42 |
